Formulation Development White Papers & Articles

  1. Flow Chemistry Vs. Batch Processes 6/10/2025

    Explore how continuous flow chemistry can accelerate your chemical development with greater efficiency, safety, and sustainability compared to traditional batch processes.

  2. 5 Key Considerations For Companies Outsourcing Process Development 6/9/2025

    Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.

  3. Preclinical Immuno-Oncology Models For CAR T-Cell Therapy Development 5/21/2025

    The following preclinical IND-enabling oncology studies conducted by scientists at Aragen over the past 10 years highlight the role of robust preclinical models in advancing the fight against cancer.

  4. Preclinical Model Of Post- Incisional Pain For Efficacy Testing Of Novel Therapeutics 5/16/2025

    Explore how validated preclinical models of incision-induced pain can accelerate the development of effective therapies for postoperative pain by closely mimicking human pain responses.

  5. Nanomedicine Modalities Find Path To Clinic Through Analytics 5/16/2025

    Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.

  6. Cost And Scalability Key Drivers Of Expanded Gene Therapy Access 5/16/2025

    Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

  7. Effect Of Methylprednisolone On The Systemic Lupus Erythematosus (SLE) In Murine Models 5/13/2025

    Leverage the MRL/lpr lupus mouse model to evaluate the effectiveness of potential SLE treatments, like Methylprednisolone, in managing key symptoms such as proteinuria and autoimmune responses.

  8. CFA-Induced Inflammatory Pain Model For Testing Anti-Inflammatory Compounds 5/13/2025

    Utilize clinically relevant preclinical models like the CFA-induced inflammatory pain model to advance the development and preclinical screening of effective therapies for managing inflammatory pain.

  9. Experimental λ-Carrageenan-Induced Inflammatory Pain Model For Testing Novel Analgesics 5/13/2025

    Explore reliable and reproducible λ-Carrageenan-induced inflammatory pain models for effective preclinical screening of promising analgesic candidates targeting chronic pain.

  10. Mass Spectrometry For Drug-Protein Interaction 5/13/2025

    Discover how mass spectrometry can transform your drug discovery efforts by delivering precise, reliable quantification of drug-protein interactions for optimized assay development and dosing strategies.